Clinical Research Directory
Browse clinical research sites, groups, and studies.
Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control
Sponsor: Ruihua Wei
Summary
To evaluate the effectiveness and safety of DIMS, low concentration atropine eye drops,and atropine combined with DIMS in controlling axial length and refraction in children with moderate to high myopia.
Official title: Efficacy and Safety of Low-concentration Atropine Eye Drops (0.02%, 0.04%) Combined With Defocus Incorporated Multiple Segments (DIMS) for Moderate and High Myopia Control
Key Details
Gender
All
Age Range
6 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
410
Start Date
2024-02-01
Completion Date
2026-03-31
Last Updated
2025-09-08
Healthy Volunteers
No
Conditions
Interventions
DIMS
wear DIMS ,and use placebo,once nightly, both eye
The 0.02% ATP Group
wear SP, and use 0.02%ATP eye drops, once nightly, both eye
The 0.04% ATP Group
wear SP, and use 0.04%ATP eye drops, once nightly, both eye
0.02%ATP+DIMS
wear DIMS, and use 0.02%ATP eye drops, once nightly, both eye
0.04%ATP+DIMS
wear DIMS, and use 0.04%ATP eye drops, once nightly, both eye
Locations (1)
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China